Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapy

Cancer is a worldwide health problem. Personalized treatment represents a future advancement for cancer treatment, in part due to the development of targeted therapeutic drugs. These molecules are expected to be more effective than current treatments and less harmful to normal cells. The discovery and validation of new targets are the foundation and the source of these new therapies. The neurotensinergic system has been shown to enhance cancer progression in various cancers such as pancreatic, prostate, lung, breast, and colon cancer. It also triggers multiple oncogenic signaling pathways, such as the PKC/ERK and AKT pathways. In this review, we discuss the contribution of the neurotensinergic system to cancer progression, as well as the regulation and mechanisms of the system in order to highlight its potential as a therapeutic target, and its prospect for its use as a treatment in certain cancers.

[1]  J. Long,et al.  microRNA signature for human pancreatic cancer invasion and metastasis. , 2012, Experimental and therapeutic medicine.

[2]  P Ferrara,et al.  Molecular cloning of a levocabastine‐sensitive neurotensin binding site , 1996, FEBS letters.

[3]  H. Kataoka.  EGFR ligands and their signaling scissors, ADAMs, as new molecular targets for anticancer treatments. , 2009, Journal of dermatological science.

[4]  P. Mallorga,et al.  The effects of deleting the mouse neurotensin receptor NTR1 on central and peripheral responses to neurotensin. , 2002, The Journal of pharmacology and experimental therapeutics.

[5]  G. Powis,et al.  Neurotensin is an autocrine trophic factor stimulated by androgen withdrawal in human prostate cancer. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[6]  H. Wang,et al.  G alpha q/11 mediates neurotensin excitation of substantia nigra dopaminergic neurons. , 1996, Brain research. Molecular brain research.

[7]  J. Maloteaux,et al.  Cytoskeleton‐related trafficking of the EAAC1 glutamate transporter after activation of the Gq/11‐coupled neurotensin receptor NTS1 , 2002, FEBS letters.

[8]  P. Mires.  Lines , 2006 .

[9]  B. Evers,et al.  Curcumin Inhibits Neurotensin-Mediated Interleukin-8 Production and Migration of HCT116 Human Colon Cancer Cells , 2006, Clinical Cancer Research.

[10]  J. T. Turner,et al.  Regulation of the neurotensin receptor and intracellular calcium mobilization in HT29 cells. , 1990, The Journal of pharmacology and experimental therapeutics.

[11]  E. Guillemare,et al.  Effects of SR 48692 on neurotensin-induced calcium-activated chloride currents in the Xenopus oocyte expression system: agonist-like activity on the levocabastine-sensitive neurotensin receptor and absence of antagonist effect on the levocabastine insensitive neurotensin receptor , 1997, Neuroscience Letters.

[12]  C. Pothoulakis,et al.  The neurotensin receptor‐1 promotes tumor development in a sporadic but not an inflammation‐associated mouse model of colon cancer , 2012, International journal of cancer.

[13]  T. Moody,et al.  SR48692 is a neurotensin receptor antagonist which inhibits the growth of small cell lung cancer cells , 2001, Peptides.

[14]  B. Groner,et al.  Evaluation of cell surface antigens as potential targets for recombinant tumor toxins. , 1997, Cancer letters.

[15]  D. Gully,et al.  Effect of the neurotensin receptor antagonist SR48692 on rat blood pressure modulation by neurotensin. , 1996, Life sciences.

[16]  R. Carraway,et al.  The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. , 1973, The Journal of biological chemistry.

[17]  K. Chan,et al.  CD133+ liver tumor‐initiating cells promote tumor angiogenesis, growth, and self‐renewal through neurotensin/interleukin‐8/CXCL1 signaling , 2012, Hepatology.

[18]  M. E. Starr,et al.  PI3K p110α/Akt signaling negatively regulates secretion of the intestinal peptide neurotensin through interference of granule transport. , 2012, Molecular endocrinology.

[19]  P. Forgez,et al.  Neurotensin Agonist Induces Differential Regulation of Neurotensin Receptor mRNA , 1997, The Journal of Biological Chemistry.

[20]  Qingzhen Zhao,et al.  DNA methylation contributes to expression of the human neurotensin/neuromedin N gene. , 1998, American journal of physiology. Gastrointestinal and liver physiology.

[21]  Ning-ning Li,et al.  Pancreatic cancer bears overexpression of neurotensin and neurotensin receptor subtype-1 and SR 48692 counteracts neurotensin induced cell proliferation in human pancreatic ductal carcinoma cell line PANC-1 , 2011, Neuropeptides.

[22]  T. Ulich,et al.  A colonic adenocarcinoma with argentaffin cells an immunoperoxidase study demonstrating the presence of numerous neuroendocrine products , 1983, Cancer.

[23]  E. Richelson,et al.  Neurotensin Stimulates Inositol Phospholipid Metabolism and Calcium Mobilization in Murine Neuroblastoma Clone N1E‐115 , 1986, Journal of neurochemistry.

[24]  J. Vincent,et al.  Functional roles of the NTS2 and NTS3 receptors , 2006, Peptides.

[25]  Sara M. Johnson,et al.  Suppression of Neurotensin Receptor Type 1 Expression and Function by Histone Deacetylase Inhibitors in Human Colorectal Cancers , 2010, Molecular Cancer Therapeutics.

[26]  P. Soubrié,et al.  Targeted inactivation of the neurotensin type 1 receptor reveals its role in body temperature control and feeding behavior but not in analgesia , 2002, Brain Research.

[27]  K. Xie,et al.  Interleukin-8 and human cancer biology. , 2001, Cytokine & growth factor reviews.

[28]  G. Guzman,et al.  Increased neurotensin receptor-1 expression during progression of colonic adenocarcinoma , 2008, Peptides.

[29]  Y. Okamoto,et al.  Identification of a novel therapeutic target for head and neck squamous cell carcinomas: A role for the neurotensin‐neurotensin receptor 1 oncogenic signaling pathway , 2008, International journal of cancer.

[30]  B. Evers,et al.  Expression of the Neurotensin Gene in Fetal Human Liver and Fibrolamellar Carcinoma , 1994, Annals of Surgery.

[31]  C. Haslett,et al.  Neuropeptides stimulate tyrosine phosphorylation and tyrosine kinase activity in small cell lung cancer cell lines , 1996, Peptides.

[32]  C. Pothoulakis,et al.  Neurotensin stimulates IL-8 expression in human colonic epithelial cells through Rho GTPase-mediated NF-kappa B pathways. , 2003, American journal of physiology. Cell physiology.

[33]  L. Miller,et al.  Neurotensin Receptor 1 Determines the Outcome of Non–Small Cell Lung Cancer , 2010, Clinical Cancer Research.

[34]  Yuning Zhou,et al.  Neurotensin Phosphorylates GSK-3α/β through the Activation of PKC in Human Colon Cancer Cells , 2006 .

[35]  R. Kiss,et al.  The in vitro influences of neurotensin on the motility characteristics of human U373 glioblastoma cells , 2006, Neuropathology and applied neurobiology.

[36]  A. Beaudet,et al.  Low-Affinity Neurotensin Receptor (NTS2) Signaling: Internalization-Dependent Activation of Extracellular Signal-Regulated Kinases 1/2 , 2004, Molecular Pharmacology.

[37]  R. Carraway,et al.  Involvement of neurotensin in cancer growth: Evidence, mechanisms and development of diagnostic tools , 2006, Peptides.

[38]  P. Vogel,et al.  Time course of the hypothermic response to continuously administered neurotensin , 2007, Neuropeptides.

[39]  T. Hökfelt,et al.  Report on a patient with watery diarrhoea syndrome caused by a pancreatic tumour containing neurotensin, enkephalin and calcitonin. , 2009, Acta medica Scandinavica.

[40]  P. Forgez,et al.  Molecular and cellular regulation of neurotensin receptor under acute and chronic agonist stimulation , 2006, Peptides.

[41]  B. Evers,et al.  The neurotensin gene is a downstream target for Ras activation. , 1995, The Journal of clinical investigation.

[42]  Yuning Zhou,et al.  Neurotensin phosphorylates GSK-3alpha/beta through the activation of PKC in human colon cancer cells. , 2006, Neoplasia.

[43]  G. Turashvili,et al.  Wnt Signaling Pathway in Mammary Gland Development and Carcinogenesis , 2007, Pathobiology.

[44]  C. Pothoulakis,et al.  Neurotensin-induced Proinflammatory Signaling in Human Colonocytes Is Regulated by β-Arrestins and Endothelin-converting Enzyme-1-dependent Endocytosis and Resensitization of Neurotensin Receptor 1* , 2012, The Journal of Biological Chemistry.

[45]  Philippe Sarret,et al.  Structure, Functional Expression, and Cerebral Localization of the Levocabastine-Sensitive Neurotensin/Neuromedin N Receptor from Mouse Brain , 1996, The Journal of Neuroscience.

[46]  R. Kiss,et al.  Neurotensin is a Versatile Modulator of In Vitro Human Pancreatic Ductal Adenocarcinoma Cell (PDAC) Migration , 2007, Cellular oncology : the official journal of the International Society for Cellular Oncology.

[47]  N. Tommerup,et al.  Molecular Identification of a Novel Candidate Sorting Receptor Purified from Human Brain by Receptor-associated Protein Affinity Chromatography* , 1997, The Journal of Biological Chemistry.

[48]  P. Forgez,et al.  The Neurotensin Receptor-1 Pathway Contributes to Human Ductal Breast Cancer Progression , 2009, PloS one.

[49]  D. Tourwé,et al.  A stable neurotensin-based radiopharmaceutical for targeted imaging and therapy of neurotensin receptor-positive tumours , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[50]  D. Gully,et al.  Neurotensin type 1 receptor‐mediated activation of krox24, c‐fos and Elk‐1: preventing effect of the neurotensin antagonists SR 48692 and SR 142948 , 1998, FEBS letters.

[51]  P. Forgez,et al.  Neurotensin expression and outcome of malignant pleural mesothelioma. , 2010, Biochimie.

[52]  B. Evers,et al.  Neurotensin-mediated activation of MAPK pathways and AP-1 binding in the human pancreatic cancer cell line, MIA PaCa-2. , 2000, Biochemical and biophysical research communications.

[53]  P. Forgez,et al.  Neurotensin counteracts apoptosis in breast cancer cells. , 2002, Biochemical and biophysical research communications.

[54]  MoonnohR . Lee,et al.  Neurotensin receptor type 1 regulates ethanol intoxication and consumption in mice , 2010, Pharmacology Biochemistry and Behavior.

[55]  J. Ødegård,et al.  Role of protein kinase C and epidermal growth factor receptor signalling in growth stimulation by neurotensin in colon carcinoma cells , 2011, BMC Cancer.

[56]  R. Carraway,et al.  Involvement of MAP-kinase, PI3-kinase and EGF-receptor in the stimulatory effect of Neurotensin on DNA synthesis in PC3 cells , 2004, Regulatory Peptides.

[57]  Stéphane Martin,et al.  Neurotensin receptor-1 and -3 complex modulates the cellular signaling of neurotensin in the HT29 cell line. , 2002, Gastroenterology.

[58]  A. Blackburn.  Neurotensin. , 1978, Journal of clinical pathology. Supplement.

[59]  G. Amorino,et al.  Neurotensin stimulates mitogenesis of prostate cancer cells through a novel c-Src/Stat5b pathway , 2007, Oncogene.

[60]  H. Friess,et al.  Neurotensin receptor-1 mRNA analysis in normal pancreas and pancreatic disease. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[61]  M. Mareel,et al.  Neurotensin receptor 1 gene activation by the Tcf/beta-catenin pathway is an early event in human colonic adenomas. , 2006, Carcinogenesis.

[62]  E. Rozengurt,et al.  Neurotensin stimulates protein kinase C-dependent mitogenic signaling in human pancreatic carcinoma cell line PANC-1. , 2003, Cancer research.

[63]  M. Laburthe,et al.  Neurotensin and a non‐peptide neurotensin receptor antagonist control human colon cancer cell growth in cell culture and in cells xenografted into nude mice , 1999, International journal of cancer.

[64]  R. Carraway,et al.  Neurotensin receptor expression in prostate cancer cell line and growth effect of NT at physiological concentrations , 1997, The Prostate.

[65]  S. Menichetti,et al.  Design and In vitro Evaluation of Branched Peptide Conjugates: Turning Nonspecific Cytotoxic Drugs into Tumor‐Selective Agents , 2010, ChemMedChem.

[66]  N. Metzler‐Nolte,et al.  Synthesis and in vitro cytotoxicity of cis,cis,trans-diamminedichloridodisuccinatoplatinum(IV)-peptide bioconjugates. , 2012, Metallomics : integrated biometal science.

[67]  J. Barbet,et al.  Novel neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumors. , 2009, Bioconjugate chemistry.

[68]  Eun Ran Kim,et al.  Impaired anorectic effect of leptin in neurotensin receptor 1-deficient mice , 2008, Behavioural Brain Research.

[69]  P. Forgez,et al.  Activation of Receptor Gene Transcription Is Required to Maintain Cell Sensitization after Agonist Exposure , 1998, The Journal of Biological Chemistry.

[70]  M. Suzui,et al.  Circulating MicroRNAs in Serum of Human K-ras Oncogene Transgenic Rats With Pancreatic Ductal Adenocarcinomas , 2012, Pancreas.

[71]  C. Pothoulakis,et al.  Neurotensin stimulates expression of early growth response gene‐1 and EGF receptor through MAP kinase activation in human colonic epithelial cells , 2007, International journal of cancer.

[72]  S. Menichetti,et al.  Modular branched neurotensin peptides for tumor target tracing and receptor-mediated therapy: a proof-of-concept. , 2010, Current cancer drug targets.

[73]  G. Olivecrona,et al.  Sortilin/Neurotensin Receptor-3 Binds and Mediates Degradation of Lipoprotein Lipase* , 1999, The Journal of Biological Chemistry.

[74]  B. Evers,et al.  Role of gastrointestinal hormones in the proliferation of normal and neoplastic tissues. , 2003, Endocrine reviews.

[75]  B. Evers,et al.  Inhibition of neurotensin‐induced pancreatic carcinoma growth by a nonpeptide neurotensin receptor antagonist, SR48692 , 1997, Cancer.

[76]  M. Reinecke.  Neurotensin. Immunohistochemical localization in central and peripheral nervous system and in endocrine cells and its functional role as neurotransmitter and endocrine hormone. , 1985, Progress in histochemistry and cytochemistry.

[77]  B. Evers,et al.  Site-specific DNA methylation contributes to neurotensin/neuromedin N expression in colon cancers. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[78]  P. Kitabgi,et al.  Neurotensin-mediated inhibition of cyclic AMP formation in neuroblastoma N1E115 cells: involvement of the inhibitory GTP-binding component of adenylate cyclase. , 1986, Molecular pharmacology.

[79]  R. Jensen,et al.  Neurotensin causes tyrosine phosphorylation of focal adhesion kinase in lung cancer cells. , 2002, European journal of pharmacology.

[80]  Masayuki Masu,et al.  Structure and functional expression of the cloned rat neurotensin receptor , 1990, Neuron.

[81]  J. Talbot,et al.  Novel DOTA-neurotensin analogues for 111In scintigraphy and 68Ga PET imaging of neurotensin receptor-positive tumors. , 2011, Bioconjugate chemistry.

[82]  F. St-Gelais,et al.  The role of neurotensin in central nervous system pathophysiology: what is the evidence? , 2006, Journal of psychiatry & neuroscience : JPN.

[83]  P. Forgez,et al.  NT Agonist Regulates Expression of Nuclear High-affinity Neurotensin Receptors , 2004, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[84]  N. Maitland,et al.  Altered expression of neurotensin receptors is associated with the differentiation state of prostate cancer. , 2010, Cancer research.

[85]  G. Amorino,et al.  Inhibition of neurotensin receptor 1 selectively sensitizes prostate cancer to ionizing radiation. , 2011, Cancer research.

[86]  C. Röcken,et al.  Immunocytochemical identification of low-affinity NTS2 neurotensin receptors in parietal cells of human gastric mucosa. , 2006, The Journal of endocrinology.

[87]  M. Lafrance,et al.  Altered morphine-induced analgesia in neurotensin type 1 receptor null mice , 2010, Neuroscience.

[88]  J. Minna,et al.  Neurotensin is produced by and secreted from classic small cell lung cancer cells. , 1985, Life sciences.

[89]  F. Massa,et al.  Neurotensin receptor-2 and -3 are crucial for the anti-apoptotic effect of neurotensin on pancreatic beta-TC3 cells. , 2009, The international journal of biochemistry & cell biology.

[90]  P. Soubrié,et al.  Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist. , 1997, The Journal of pharmacology and experimental therapeutics.

[91]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[92]  P. Soubrié,et al.  Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[93]  U. Weidle,et al.  Identification of genes associated with enhanced metastasis of a large cell lung carcinoma cell line. , 2003, Anticancer research.

[94]  S. Sumi,et al.  Comparative effects of neurotensin and neuromedin N on growth of human pancreatic cancer, MIA PaCa-2. , 1993, Surgical oncology.

[95]  R. Narayanan,et al.  Relevant genomics of neurotensin receptor in cancer. , 2000, Anticancer research.

[96]  V. K. Doan,et al.  The potential use of the neurotensin high affinity receptor 1 as a biomarker for cancer progression and as a component of personalized medicine in selective cancers. , 2011, Biochimie.

[97]  W. Isaacs,et al.  In vitro evidence for complex modes of nuclear β-catenin signaling during prostate growth and tumorigenesis , 2002, Oncogene.

[98]  B. Evers,et al.  Neurotensin stimulates growth of colon cancer. , 1992, Surgical oncology.

[99]  Stéphane Martin,et al.  Involvement of the Neurotensin Receptor-3 in the Neurotensin-Induced Migration of Human Microglia , 2003, The Journal of Neuroscience.

[100]  M. Kuwano,et al.  Stimulation of cell‐surface urokinase‐type plasminogen activator activity and cell migration in vascular endothelial cells by a novel hexapeptide analogue of neurotensin , 1997, FEBS letters.

[101]  MoonnohR . Lee,et al.  Increased ethanol consumption and preference in mice lacking neurotensin receptor type 2. , 2011, Alcoholism, clinical and experimental research.

[102]  C. Morales,et al.  The lysosomal trafficking of sphingolipid activator proteins (SAPs) is mediated by sortilin , 2003, The EMBO journal.

[103]  E. Rozengurt,et al.  Induced overexpression of protein kinase D1 stimulates mitogenic signaling in human pancreatic carcinoma PANC‐1 cells , 2010, Journal of cellular physiology.

[104]  J. Vincent,et al.  Neurotensin protects pancreatic beta cells from apoptosis. , 2008, The international journal of biochemistry & cell biology.

[105]  P. Forgez,et al.  Biophysical characteristics of neurotensin polyplex for in vitro and in vivo gene transfection. , 2006, Biochimica et biophysica acta.

[106]  P. Forgez,et al.  Distinct functional characteristics of levocabastine sensitive rat neurotensin NT2 receptor expressed in Chinese hamster ovary cells. , 1998, Life sciences.

[107]  P. Sindou,et al.  Differential Expression of Neurotensin and Specific Receptors, NTSR1 and NTSR2, in Normal and Malignant Human B Lymphocytes , 2012, The Journal of Immunology.

[108]  P. Dempsey,et al.  Control of ErbB signaling through metalloprotease mediated ectodomain shedding of EGF-like factors , 2006, Growth factors.

[109]  W. Mustain,et al.  The role of neurotensin in physiologic and pathologic processes , 2011, Current opinion in endocrinology, diabetes, and obesity.

[110]  B. Aggarwal,et al.  A Novel Small-Molecule Inhibitor of Protein Kinase D Blocks Pancreatic Cancer Growth In vitro and In vivo , 2010, Molecular Cancer Therapeutics.

[111]  Samir Attoub,et al.  Expression of neurotensin and NT1 receptor in human breast cancer: a potential role in tumor progression. , 2006, Cancer research.

[112]  I. Mills,et al.  A role for neurotensin in bicalutamide resistant prostate cancer cells , 2007, The Prostate.

[113]  G. Kahaly,et al.  Multiple peptide hormone producing adenocarcinoma of lung with neurotensin and CRF-like immunoreactivity. , 1988, Pathology, research and practice.

[114]  P. Casellas,et al.  Activation of mitogen-activated protein kinase couples neurotensin receptor stimulation to induction of the primary response gene Krox-24. , 1996, The Biochemical journal.

[115]  T. Seufferlein,et al.  Galanin, neurotensin, and phorbol esters rapidly stimulate activation of mitogen-activated protein kinase in small cell lung cancer cells. , 1996, Cancer research.

[116]  J. Leysen,et al.  Evidence for a displaceable non-specific [3H]neurotensin binding site in rat brain , 1986, Naunyn-Schmiedeberg's Archives of Pharmacology.

[117]  J P Vincent,et al.  Neurotensin and neurotensin receptors. , 1999, Trends in pharmacological sciences.

[118]  P. Forgez,et al.  NT-polyplex: a new tool for therapeutic gene delivery to neuroblastoma tumors , 2009, Cancer Gene Therapy.

[119]  H. Kung,et al.  Neuropeptide-Induced Androgen Independence in Prostate Cancer Cells: Roles of Nonreceptor Tyrosine Kinases Etk/Bmx, Src, and Focal Adhesion Kinase , 2001, Molecular and Cellular Biology.